Our results show that Wnt3A upregulates canonical β-catenin targets in ovarian cancer cells with functional BRCA1 and BRCA2, particularly the full-length WT Tcf1/7, c-Myc, and cyclin D1. The gene discussed is WNT3A; the disease is ovarian cancer.